Literature DB >> 33779167

The Antiviral Enzyme, Viperin, Activates Protein Ubiquitination by the E3 Ubiquitin Ligase, TRAF6.

Ayesha M Patel1, E Neil G Marsh1.   

Abstract

Viperin is a broadly conserved radical SAM enzyme that synthesizes the antiviral nucleotide ddhCTP. In higher animals, viperin expression also accelerates the degradation of various cellular and viral proteins necessary for viral replication; however, the details of this process remain largely unknown. Here, we show that viperin activates a component of the protein ubiquitination machinery, which plays an important role in both protein degradation and immune signaling pathways. We demonstrate that viperin binds the E3 ubiquitin ligase, TRAF6, which catalyzes K63-linked ubiquitination associated with immune signaling pathways. Viperin activates ubiquitin transfer by TRAF6-2.5-fold and causes a significant increase in polyubiquitinated forms of TRAF6 that are important for mediating signal transduction. Our observations both imply a role for viperin as an agonist of immune signaling and suggest that viperin may activate other K48-linked E3-ligases involved in targeting proteins for proteasomal degradation.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33779167     DOI: 10.1021/jacs.1c01045

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   16.383


  3 in total

1.  Viperin-taken down with a pinch of salt.

Authors:  Soumi Ghosh; E Neil G Marsh
Journal:  EMBO Rep       Date:  2021-11-19       Impact factor: 8.807

2.  Purification of the full-length, membrane-associated form of the antiviral enzyme viperin utilizing nanodiscs.

Authors:  Ayesha M Patel; Karl J Koebke; Timothy J Grunkemeyer; Colleen M Riordan; Youngsoo Kim; Ryan C Bailey; E Neil G Marsh
Journal:  Sci Rep       Date:  2022-07-13       Impact factor: 4.996

3.  Identification and analysis of mitochondria-related key genes of heart failure.

Authors:  Haozhen Yu; Mujun Yu; Zhuang Li; Enhu Zhang; Heng Ma
Journal:  J Transl Med       Date:  2022-09-07       Impact factor: 8.440

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.